nimbolide has been researched along with Angiogenesis, Pathologic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arvindh, S; Baba, AB; Gade, DR; Gopal, G; K, C; Nagini, S; Nivetha, R; Reddy, GB; Reddy, KP | 1 |
| Aggarwal, N; Bharti, AC; Chaudhary, A; Chhokar, A; Goswami, N; Janjua, D; Joshi, U; Senrung, A; Tripathi, T; Yadav, J | 1 |
| Anbarasu, K; Dixit, M; Kowshik, J; Mahalingam, S; Mishra, R; Nagini, S; Rautray, S; Reddy, GD; Sophia, J | 1 |
| Goh, BC; Ho, PC; Lee, SC; Ong, PS; Phan, DD; Sethi, G; Soo, R; Thuya, WL; Wang, L; Wong, AL; Yong, WP; Zhang, J | 1 |
| Kumar, GH; Manikandan, P; Nagini, S; Priyadarsini, RV | 1 |
| Babykutty, S; Gopala, S; J, NR; Kumar, MA; Nair, MS; S, PP; Srinivas, P | 1 |
1 review(s) available for nimbolide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development.
Topics: Animals; Apoptosis; Azadirachta; Cell Proliferation; Humans; Limonins; Neoplasms; Neovascularization, Pathologic; Phytotherapy; Plant Extracts | 2016 |
5 other study(ies) available for nimbolide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling.
Topics: Aldehyde Reductase; Animals; Azadirachta; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Female; Humans; Insulin-Like Growth Factor I; Limonins; Mice; Mice, Nude; MicroRNAs; Molecular Docking Simulation; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2022 |
In vivo antiangiogenic effect of nimbolide, trans-chalcone and piperine for use against glioblastoma.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Chalcones; Glioblastoma; Humans; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2023 |
Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Cricetinae; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Limonins; Male; MicroRNAs; Neovascularization, Pathologic; RNA Interference; Signal Transduction | 2017 |
The neem limonoids azadirachtin and nimbolide inhibit hamster cheek pouch carcinogenesis by modulating xenobiotic-metabolizing enzymes, DNA damage, antioxidants, invasion and angiogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Antioxidants; Base Sequence; Cheek; Cricetinae; DNA Damage; DNA Primers; Enzymes; Free Radical Scavengers; In Vitro Techniques; Limonins; Male; Mesocricetus; Mouth Mucosa; Neoplasm Invasiveness; Neoplasms, Experimental; Neovascularization, Pathologic; Xenobiotics | 2009 |
Nimbolide retards tumor cell migration, invasion, and angiogenesis by downregulating MMP-2/9 expression via inhibiting ERK1/2 and reducing DNA-binding activity of NF-κB in colon cancer cells.
Topics: Antineoplastic Agents; Caspases; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Cyclin A; Cyclin D1; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Limonins; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Promoter Regions, Genetic; RNA, Messenger; Vascular Endothelial Growth Factor A | 2012 |